MKI67 and cancer: Third, our gene targeting results strongly suggest that Ki-67 may serve as a viable target for cancer therapy, since decreasing the stem cell compartment of solid tumors would abrogate the ability of these cancers to quickly proliferate as single cell metastases, and may help eradicate an inherently drug resistant population of cancer cells.